Rapamycin ameliorates proteinuria-associated tubulointerstitial inflammation and fibrosis in experimental membranous nephropathy

RGB Bonegio, R Fuhro, Z Wang… - Journal of the …, 2005 - journals.lww.com
Proteinuria is a risk factor for progression of chronic renal failure. A model of proteinuria-
associated tubulointerstitial injury was developed and was used to examine the therapeutic
effect of rapamycin. Two studies were performed. In study A, proteinuric rats were given
sheep anti-Fx1A to induce experimental membranous nephropathy; control rats received
normal sheep serum. Four weeks later, groups were subdivided and underwent laparotomy
alone (two kidneys), nephrectomy alone (one kidney), or nephrectomy with polectomy (0.6 …
以上显示的是最相近的搜索结果。 查看全部搜索结果